US Stock Futures Rise Ahead Of Economic Data - Ayala Pharmaceuticals (OTC:ADXS), Alkermes (NASDAQ:ALKS)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Pre-open moversUS stock futures traded higher in early pre-market trade. The Chicago Fed National Activity Index for July will be released at 8:30 a.m. ET, while the Markit PMI services index (flash) for August will be released at 9:45 a.m. ET. Data on new home sales for July will be released at 10:00 a.m. ET, while the Dallas Fed general business activity index for August will be released at 10:30 a.m. ET. Futures for the Dow Jones Industrial Average jumped 42 points to 17,035.00, while the Standard & Poor's 500 index futures rose 5.90 points to 1,993.70. Futures for the Nasdaq 100 index climbed 14.25 points to 4,069.00.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

A Peek Into Global Markets European markets were mostly higher today, with the Spanish Ibex Index rising 0.92%, STOXX Europe 600 Index gaining 0.66%. German DAX 30 index gained 1.03%, French CAC 40 Index climbed 1.12% and London's FTSE 100 Index dropped 0.04%.In Asian markets, Japan's Nikkei Stock Average rose 0.48%, Hong Kong's Hang Seng Index gained 0.22%, China's Shanghai Composite Index declined 0.51% and India's Sensex gained 0.07%.Broker Recommendation

Analysts at Credit Suisse upgraded United States Steel (NYSE: X) from Underperform to Outperform. The target price for United States Steel has been raised from $22 to $50. United States Steel's shares closed at $37.81 on Friday. Breaking news

Advaxis (NASDAQ: ADXS) has entered into a clinical trial collaboration agreement with Merck (NYSE: MRK) to evaluate the combination of Advaxis's Lm-LLO cancer immunotherapy, ADXS-PSA, with Merck's investigational anti PD-1 antibody, pembrolizumab. To read the full news, click here.
Alkermes (NASDAQ: ALKS) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of aripiprazole lauroxil, the company's investigational, novel, once-monthly, long-acting injectable atypical antipsychotic for the treatment of schizophrenia. To read the full news, click here.
Roche (OTC: RHHBY) and InterMune (NASDAQ: ITMN) today announced they have entered into a definitive merger agreement for Roche to fully acquire InterMune at a price of $74.00 per share in an all-cash transaction. This corresponds to a total transaction value of $8.3 billion on a fully diluted basis. To read the full news, click here.
In response to media reports, Tim Hortons (NYSE: THI) and Burger King Worldwide (NYSE: BKW) today confirmed that they are in discussions regarding the potential creation of a global leader in the quick service restaurant business. To read the full news, click here.